2023 Fall Vaccine UpdateOn-demand WebinarThis presentation reviews the three respiratory viruses anticipated to be epidemic during the fall/winter season (influenza, COVID-19, RSV) and their vaccination recommendations, with a focus on the Respiratory Syncytial Virus (RSV). RSV disease in adults is underreported and underrecognized in the U.S. The burden of RSV disease in adults is reviewed along with the target adult population who would most benefit from RSV vaccination. Intended AudienceFamily physicians, family medicine residents, medical students, and life members FacultyPamela Rockwell, DO, FAAFP CMEThe AAFP has reviewed 2023 Fall Vaccine Update - Enduring and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credits. Term of Approval is from 11/09/2023 to 11/09/2024. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Cost
|